QDEL logo

QuidelOrtho (QDEL) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

01 February 1991

Indexes:

Not included

Description:

Quidel Corporation is a manufacturer of medical diagnostic supplies. The company produces a wide range of tests, reagents, devices, and other products for diagnosing viral and bacterial infections, autoimmune diseases, and detecting markers of inflammation. The company also produces bacterial cultures, conducts research in the field of diagnosing oncological diseases, diabetes, and so on. One of the popular solutions from Quidel is the Triage device for rapid detection of prohibited substances in patients' bodies. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.

Events Calendar

Earnings

Next earnings date:

Feb 13, 2025

Recent quarterly earnings:

Nov 07, 2024

Recent annual earnings:

Feb 13, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

11 Dec '24 Citigroup
Buy
10 Dec '24 Jefferies
Hold
16 Aug '24 RBC Capital
Outperform
01 Aug '24 RBC Capital
Outperform
09 May '24 RBC Capital
Outperform
04 Mar '24 UBS
Sell
14 Feb '24 William Blair
Market Perform
14 Feb '24 Raymond James
Outperform
14 Feb '24 RBC Capital
Outperform
14 Feb '24 JP Morgan
Underweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL
zacks.com04 December 2024

QDEL continues to witness growth on the back of its strong product portfolio.

QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
QDEL
businesswire.com19 November 2024

SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today the launch of an underwritten secondary offering (the “Offering”) by Carlyle Partners VI Cayman Holdings, L.P. (the “Selling Stockholder”) of 8,260,183 shares of the Company's common stock (“Common Stock”). The Selling Stockholder will rec.

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm
QDEL
prnewswire.com13 November 2024

NEW YORK , Nov. 13, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of QuidelOrtho Corporation (NASDAQ: QDEL)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, QuidelOrtho insiders caused the company to misrepresent or fail to disclose that (a) QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers and end customers; (b) excess inventories of COVID-19 tests existed throughout the supply chain; (c) as a result, QuidelOrtho's distributors and pharmacy chain customers were poised to significantly reduce their COVID-19 test orders; (d) undisclosed problems created a heightened risk that the new test called the savanna respiratory viral panel-4 test would experience a delayed commercial launch in the United States; (e) as a result, the company lacked a reasonable basis for positive statements about QuidelOrtho's business, financials, and growth trajectory.

QuidelOrtho Stock Rises as Q3 Earnings & Revenues Beat Estimates
QuidelOrtho Stock Rises as Q3 Earnings & Revenues Beat Estimates
QuidelOrtho Stock Rises as Q3 Earnings & Revenues Beat Estimates
QDEL
zacks.com08 November 2024

QDEL's third-quarter results reflect growth in non-respiratory revenues along with a lowering of operating expenses year over year. However, the gross margin declines in the reported quarter.

QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue Estimates
QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue Estimates
QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue Estimates
QDEL
zacks.com07 November 2024

QuidelOrtho (QDEL) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.90 per share a year ago.

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm
QDEL
globenewswire.com31 October 2024

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of QuidelOrtho Corporation (NASDAQ: QDEL) breached their fiduciary duties to shareholders.

QuidelOrtho to Participate in Three Upcoming Investor Conferences
QuidelOrtho to Participate in Three Upcoming Investor Conferences
QuidelOrtho to Participate in Three Upcoming Investor Conferences
QDEL
businesswire.com28 October 2024

SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team will attend three upcoming investor conferences and participate in fireside chats at all three conferences. UBS Global Healthcare Conference On Tuesday, November 12, 2024, QuidelOrtho is scheduled to part.

Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL
zacks.com08 October 2024

QDEL's strong product portfolio raises optimism about the stock.

Why QuidelOrtho Stock Blasted 10% Higher Today
Why QuidelOrtho Stock Blasted 10% Higher Today
Why QuidelOrtho Stock Blasted 10% Higher Today
QDEL
fool.com05 September 2024

An analyst became notably more bullish on the diagnostics company's prospects. He upgraded his recommendation from hold to buy.

Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL
zacks.com03 September 2024

QDEL's strong product portfolio raises optimism about the stock.

FAQ

  • What is the primary business of QuidelOrtho?
  • What is the ticker symbol for QuidelOrtho?
  • Does QuidelOrtho pay dividends?
  • What sector is QuidelOrtho in?
  • What industry is QuidelOrtho in?
  • What country is QuidelOrtho based in?
  • When did QuidelOrtho go public?
  • Is QuidelOrtho in the S&P 500?
  • Is QuidelOrtho in the NASDAQ 100?
  • Is QuidelOrtho in the Dow Jones?
  • When was QuidelOrtho's last earnings report?
  • When does QuidelOrtho report earnings?
  • Should I buy QuidelOrtho stock now?

What is the primary business of QuidelOrtho?

Quidel Corporation is a manufacturer of medical diagnostic supplies. The company produces a wide range of tests, reagents, devices, and other products for diagnosing viral and bacterial infections, autoimmune diseases, and detecting markers of inflammation. The company also produces bacterial cultures, conducts research in the field of diagnosing oncological diseases, diabetes, and so on. One of the popular solutions from Quidel is the Triage device for rapid detection of prohibited substances in patients' bodies. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.

What is the ticker symbol for QuidelOrtho?

The ticker symbol for QuidelOrtho is NASDAQ:QDEL

Does QuidelOrtho pay dividends?

No, QuidelOrtho does not pay dividends

What sector is QuidelOrtho in?

QuidelOrtho is in the Healthcare sector

What industry is QuidelOrtho in?

QuidelOrtho is in the Medical Devices industry

What country is QuidelOrtho based in?

QuidelOrtho is headquartered in United States

When did QuidelOrtho go public?

QuidelOrtho's initial public offering (IPO) was on 01 February 1991

Is QuidelOrtho in the S&P 500?

No, QuidelOrtho is not included in the S&P 500 index

Is QuidelOrtho in the NASDAQ 100?

No, QuidelOrtho is not included in the NASDAQ 100 index

Is QuidelOrtho in the Dow Jones?

No, QuidelOrtho is not included in the Dow Jones index

When was QuidelOrtho's last earnings report?

QuidelOrtho's most recent earnings report was on 7 November 2024

When does QuidelOrtho report earnings?

The next expected earnings date for QuidelOrtho is 13 February 2025

Should I buy QuidelOrtho stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions